Skip to main content

Cancer Research UK

Cancer Research UK (CRUK) and the National Cancer Registration and Analysis Service (NCRAS) work in partnership to provide high quality and impactful intelligence to support in improving cancer service delivery and outcomes for patients.  

Background

In 2013 CRUK and NCRAS established a partnership to conduct analysis that both organisations see as a priority. This includes but is not limited to:

  • understanding the cancer pathway better and timeliness of patients receiving treatment  
  • increasing our understanding of survival in cancer patients  
  • analysing cancer outcomes from diagnosis through treatment
  • investigating inequalities across the cancer pathway 

Outputs

The partnership has contributed to many outputs over the years, with some highlighted and linked to below. 

Latest publication - The number and proportion of cancer patients receiving drugs Cancer Research UK helped to develop

The partnership team have analysed the systemic anti-cancer therapies (SACT) data to investigate how many cancer patients were treated with a cancer drug that CRUK helped to develop. We looked at this from 2015 to 2023 in England. We also looked at how the number varied across different cancer types. 

Read the full report on the CRUK website

Previous publications

*Please note this is a historic project so there may be some differences with the more recent methodologies used by NDRS


More information

For more information, please contact [email protected] 

Last edited: 9 October 2026 9:34 am